Profusa (NVACW) Preferred Stock Liabilities (2021 - 2025)
Profusa posted quarterly Preferred Stock Liabilities of $1.3 million for Q2 2025, down 84.44% year-on-year from $8.6 million in Q2 2024, and down 32.89% on a QoQ basis from $2.0 million in Q1 2025.
Profusa (NVACW) has 5 years of Preferred Stock Liabilities data on file, last reported at $1.3 million in Q2 2025.
- For the quarter ending Q2 2025, Preferred Stock Liabilities fell 84.44% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2025 stood at $1.3 million (down 84.44% YoY), and the FY2024 full-year result was $5.2 million, down 43.46% from the prior year.
- Preferred Stock Liabilities for Q2 2025 stood at $1.3 million, down from $2.0 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $193.5 million in Q4 2022 and bottomed at $1.3 million in Q2 2025.
- The 5-year median for Preferred Stock Liabilities is $10.0 million (2023), against an average of $69.0 million.
- The widest annual swing landed in 2022, when Preferred Stock Liabilities grew 0.98%; it then slumped 95.22% in 2023.
- A 5-year view of Preferred Stock Liabilities shows it stood at $191.6 million in 2021, then advanced by 0.98% to $193.5 million in 2022, then plunged by 95.22% to $9.3 million in 2023, then slumped by 43.46% to $5.2 million in 2024, then tumbled by 74.56% to $1.3 million in 2025.
- The last three Preferred Stock Liabilities figures came in at $1.3 million (Q2 2025), $2.0 million (Q1 2025), and $5.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profusa | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 9.25 Mn |
| Sep 30, 2023 | 10.62 Mn |
| Jun 30, 2023 | 10.38 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 193.53 Mn |
| Sep 30, 2022 | 192.80 Mn |
| Jun 30, 2022 | 191.78 Mn |
| Mar 31, 2022 | 191.65 Mn |
| Dec 31, 2021 | 191.65 Mn |